Professors Sherene Loi, Grant McArthur, John Seymour and Ben Solomon have been included in the global Web of Science’s Highly Cited Researchers List for 2020.

The list was officially unveiled early this morning Australian time, and recognises the most influential researchers from across the world.

All were recognised for their research contributions in clinical medicine.

Professor Loi's research uses genomic and immunological approaches to develop new treatments for patients with breast cancer.

Professor McArthur’s research focuses on new treatments for melanoma with targeted and immunotherapies.

“Over the last year we have published our work looking at five-year survival rates for patients with metastatic melanoma, a benchmark many look to as a marker of likely long-term survival and even cure,” he says.

“Overall we believe a significant proportion of patients are being cured with advanced melanoma.”

Professor Seymour is a clinical haematologist and part of the team that developed the drug venetoclax from basic research, through clinical trials, to its position today - a blood cancer drug used around the world.

Professor Solomon is identifying and developing new targeted treatments for lung cancer, leading to the approval of new drugs and better treatment options for patients.

In a paper published in the New England Journal of Medicine today, interim results from the Phase 3 CROWN trial of the drug lorlatinib that Professor Solomon was involved in have shown it to be a potentially practice-changing treatment to delay disease progression of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer.

“Our work is made possible by the environment at Peter Mac, which allows us to involve patients in clinical research,” Professor Solomon says.

“It also reflects our ability to be part of global clinical trials due to the strength of our connections with cancers centres worldwide, and acknowledges the impact of the work we’ve been able to do with these trials.”

It is Professor Loi’s third year straight of being included on the list, and the second year in a row for Professors McArthur and Solomon.

For Professor McArthur what the recognition means is simple.

“It shows the power and recognition of scientific discoveries on the biology of cancer, and with collaborative research leading to huge impact for my patients,” he says.

“It’s all about our courageous patients.”

Peter Mac’s Executive Director Cancer Research Professor Ricky Johnstone is delighted to congratulate his colleagues on their achievements.

“We are so proud to once again be celebrating the research of Sherene, Grant, John and Ben,” he says.

“We know the research they’re part of at Peter Mac is world class, and this recognition is further evidence of that.”